1. Breast cancer cells have an increased ferroptosis risk induced by system xc− blockade after deliberately downregulating CYTL1 to mediate malignancy
   Wenwen Xue et al, 2024, Redox Biology CrossRef
2. Inhibitory effect of all-trans retinoic acid on ferroptosis in BeWo cells mediated by the upregulation of heme Oxygenase-1
   Tomona Matsuoka et al, 2024, Placenta CrossRef
3. Potential of NRF2 Inhibitors—Retinoic Acid, K67, and ML-385—In Overcoming Doxorubicin Resistance in Promyelocytic Leukemia Cells
   Michał Juszczak et al, 2024, International Journal of Molecular Sciences CrossRef
4. Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications
   Marialucia Gallorini et al, 2024, Antioxidants & Redox Signaling CrossRef
5. Mychonastes sp. 247 Induces Apoptosis of A549 Human Lung Cancer Cells by Promoting STRA6-Mediated Reactive Oxygen Species Production
   Soon Lee et al, 2023, Natural Product Communications CrossRef
6. IMI-driver: Integrating multi-level gene networks and multi-omics for cancer driver gene identification
   Peiting Shi et al, 2024, PLOS Computational Biology CrossRef
7. NRF2 inhibitors: Recent progress, future design and therapeutic potential
   Bingbing Lv et al, 2024, European Journal of Medicinal Chemistry CrossRef
8. Augmented Therapeutic Potential of EC-Synthetic Retinoids in Caco-2 Cancer Cells Using an In Vitro Approach
   Mohamed R. Abdelaal et al, 2022, International Journal of Molecular Sciences CrossRef
9. All‐trans retinoic acid exhibits anti‐proliferative and differentiating activity in Merkel cell carcinoma cells via retinoid pathway modulation
   Chiara Mazziotta et al, 2024, Journal of the European Academy of Dermatology and Venereology CrossRef